L

Lytix Biopharma AS
OSE:LYTIX

Watchlist Manager
Lytix Biopharma AS
OSE:LYTIX
Watchlist
Price: 6.88 NOK 0.88% Market Closed
Market Cap: 341.3m NOK
Have any thoughts about
Lytix Biopharma AS?
Write Note

Lytix Biopharma AS
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lytix Biopharma AS
Capital Expenditures Peer Comparison

Comparables:
HBC
B
BGBIO
AZT
N
NYKD
T
TRMED

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
L
Lytix Biopharma AS
OSE:LYTIX
Capital Expenditures
-kr49k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Capital Expenditures
-kr9.3m
CAGR 3-Years
45%
CAGR 5-Years
-113%
CAGR 10-Years
5%
B
Bergenbio ASA
OSE:BGBIO
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Capital Expenditures
-kr20.4m
CAGR 3-Years
-71%
CAGR 5-Years
-57%
CAGR 10-Years
-29%
N
Nykode Therapeutics ASA
OSE:NYKD
Capital Expenditures
-$1.1m
CAGR 3-Years
-124%
CAGR 5-Years
-69%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Lytix Biopharma AS's Capital Expenditures?
Capital Expenditures
-49k NOK

Based on the financial report for Dec 31, 2023, Lytix Biopharma AS's Capital Expenditures amounts to -49k NOK.

What is Lytix Biopharma AS's Capital Expenditures growth rate?
Capital Expenditures CAGR 1Y
68%

Over the last year, the Capital Expenditures growth was 68%.

Back to Top